Mycobacterium tuberculosis(MTB)utilizes multiple mechanisms to obtain antibiotic resis-tance during the treatment of infections.In addition,the biofilms,secreted by MTB,can further protect the latter from the contact with drug molecules and immune cells.These self-defending mechanisms lay a formidable challenge to develop effective therapeutic agents against chronic and recurring antibiotic-tolerant MTB infections.Although several inexpensive and effective drugs(isoniazid,rifampicin,pyra-zinamide and ethambutol)have been discovered for the treatment regimen,MTB continues to cause considerable morbidity and mortality worldwide.Antibiotic resistance and tolerance remain major global issues,and innovative therapeutic strategies are urgently needed to address the challenges associated with pathogenic bacteria.Gratifyingly,the cell wall synthesis of tubercle bacilli requires the participation of many enzymes which exclusively exist in prokaryotic organisms.These enzymes,absent in human hepa-tocytes,are recognized as promising targets to develop anti-tuberculosis drug.In this paper,we discussed the critical roles of potential drug targets in regulating cell wall synthesis of MTB.And also,we system-atically reviewed the advanced development of novel bioactive compounds or drug leads for inhibition of cell wall synthesis,including their discovery,chemical modification,in vitro and in vivo evaluation.

Wenbin Kuang;Haolin Zhang;Xiao Wang;Peng Yang

State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization,China Pharmaceutical University,Nanjing 210009,China;Department of Medicinal Chemistry,School of Pharmacy,China Pharmaceutical University,Nanjing 210009,China

药学学报（英文版）

[1]Wenbin Kuang;Haolin Zhang;Xiao Wang;Peng Yang-.Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis)[J].药学学报（英文版）,2022(08):3201-3214

zinamide,Gratifyingly,tocytes

Overcoming,Mycobacterium,tuberculosis,through,small,inhibitors,break,down,wall,synthesis,MTB,utilizes,multiple,mechanisms,obtain,antibiotic,during,treatment,infections,In,addition,biofilms,secreted,by,can,further,protect,latter,from,contact,molecules,immune,cells,These,self,defending,lay,formidable,effective,therapeutic,agents,against,chronic,recurring,tolerant,Although,several,inexpensive,drugs,isoniazid,rifampicin,pyra,ethambutol,have,been,discovered,regimen,continues,cause,considerable,morbidity,mortality,worldwide,Antibiotic,resistance,tolerance,remain,major,global,issues,innovative,strategies,are,urgently,needed,address,challenges,associated,pathogenic,bacteria,tubercle,bacilli,requires,participation,many,enzymes,which,exclusively,exist,prokaryotic,organisms,absent,human,hepa,recognized,promising,targets,this,paper,discussed,critical,roles,potential,regulating,And,also,system,atically,reviewed,advanced,development,novel,bioactive,compounds,leads,inhibition,including,their,discovery,chemical,modification,vitro,vivo,evaluation

0.669279